|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/07/16 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/07/16 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 09/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 25/08/2016 | |
| Director/Board Member | 58 | 25/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.61% | +2.63% | +59.27% | +172.29% | 1,070B | ||
| +2.65% | +4.61% | +71.11% | +66.83% | 624B | ||
| -0.06% | +1.29% | +35.84% | +88.10% | 450B | ||
| +2.14% | -2.07% | +27.62% | +22.57% | 328B | ||
| +1.87% | +1.87% | +40.58% | +42.08% | 292B | ||
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | ||
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | ||
| +0.11% | +1.29% | +25.21% | +67.75% | 198B | ||
| +3.91% | +6.48% | +20.35% | +80.77% | 161B | ||
| Average | +1.87% | +0.98% | +31.57% | +61.19% | 402.71B | |
| Weighted average by Cap. | +1.99% | +0.70% | +43.05% | +87.57% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















